Head and Neck Squamous Cell Carcinoma
3 competing products in clinical development for Head and Neck Squamous Cell Carcinoma.
Pipeline by Phase
Phase 23
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Cemiplimab + Cetuximab | Eli Lilly | Phase 2 | Recruiting | 52 |
| BB-401 | Benitec Biopharma | Phase 2 | Completed | 44 |
| Gemcitabine + ACR-368 | Acrivon Therapeutics | Phase 2 | Recruiting | 44 |